Here's the live share price of Invicta Diagnostic along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Invicta Diagnostic has declined 6.34% CAGR. Over the past year, the corresponding return has been -27.92%.
Invicta Diagnostic’s current P/E of 0.00x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Invicta Diagnostic | -12.38 | -20.80 | -27.92 | -27.92 | -27.92 | -10.34 | -6.34 |
| Apollo Hospitals Enterprise | -1.16 | 2.48 | -5.33 | 0.59 | 6.18 | 18.76 | 23.98 |
| Max Healthcare Institute | -3.23 | -6.25 | -10.99 | -18.57 | -5.99 | 30.97 | 44.84 |
| Fortis Healthcare | -4.79 | 3.44 | -17.84 | 15.01 | 35.76 | 46.25 | 39.96 |
| Narayana Hrudayalaya | -3.38 | -1.54 | 6.37 | -7.37 | 47.16 | 36.36 | 31.56 |
| Global Health | -2.85 | 2.29 | -13.82 | -11.52 | 14.37 | 37.43 | 23.11 |
| Aster DM Healthcare | -3.02 | -1.80 | -13.41 | 1.15 | 23.56 | 39.83 | 29.98 |
| Krishna Institute of Medical Sciences | -1.70 | -7.72 | -13.37 | -12.95 | 0.08 | 27.24 | 25.40 |
| Dr. Lal Pathlabs | -5.77 | -2.49 | -13.50 | -3.78 | -2.65 | 8.67 | 3.07 |
| Dr. Agarwals Health Care | -2.70 | 0.44 | -3.71 | 17.12 | 24.54 | 7.59 | 4.49 |
| Rainbow Childrens Medicare | -3.63 | -8.15 | -6.00 | -18.31 | -18.12 | 18.76 | 22.68 |
| Vijaya Diagnostic Centre | -4.64 | 1.11 | 2.90 | -2.00 | -16.95 | 34.75 | 10.03 |
| Metropolis Healthcare | -6.91 | -1.56 | -4.33 | 0.52 | 0.36 | 11.06 | -2.80 |
| Healthcare Global Enterprises | -0.01 | -8.19 | -5.03 | 20.70 | 34.99 | 32.06 | 33.55 |
| Jupiter Life Line Hospitals | -5.12 | -6.47 | -14.77 | -11.51 | -14.65 | 7.03 | 4.16 |
| Thyrocare Technologies | -2.45 | 5.70 | 8.66 | 18.03 | 66.43 | 33.84 | 7.06 |
| Park Medi World | -0.68 | -0.92 | -0.92 | -0.92 | -0.92 | -0.31 | -0.18 |
| Yatharth Hospital & Trauma Care Services | -8.90 | -8.63 | -21.54 | 2.29 | 28.58 | 24.00 | 13.77 |
| Nephrocare Health Services | -1.76 | 2.68 | 2.68 | 2.68 | 2.68 | 0.89 | 0.53 |
| Artemis Medicare Services | -4.22 | -8.02 | 10.70 | 3.65 | -15.24 | 51.65 | 62.95 |
Over the last one year, Invicta Diagnostic has declined 27.92% compared to peers like Apollo Hospitals Enterprise (6.18%), Max Healthcare Institute (-5.99%), Fortis Healthcare (35.76%). From a 5 year perspective, Invicta Diagnostic has underperformed peers relative to Apollo Hospitals Enterprise (23.98%) and Max Healthcare Institute (44.84%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 77.45 | 74.81 |
| 10 | 78.62 | 77.09 |
| 20 | 80.9 | 80.76 |
| 50 | 39.83 | 0 |
| 100 | 19.91 | 0 |
| 200 | 9.96 | 0 |
Hospitals & Medical Services
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Invicta Diagnostic is ₹69.70 as on Jan 13, 2026.
The Invicta Diagnostic is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the NSE.
The market cap of Invicta Diagnostic is ₹87.63 Cr as on Jan 13, 2026.
Today’s highest and lowest price of Invicta Diagnostic are ₹72.55 and ₹69.70.
The 52-week high/low is the highest and lowest price at which Invicta Diagnostic stock has traded in the past 52-week or nearly a year. The 52-week high of Invicta Diagnostic is ₹105.00 and 52-week low of Invicta Diagnostic is ₹65.05 as on Jan 13, 2026.
The Invicta Diagnostic has shown returns of -1.62% over the past day, -20.8% for the past month, -27.92% over 3 months, -27.92% over 1 year, -10.34% across 3 years, and -6.34% over 5 years.
P/E ratio of and PB ratio of Invicta Diagnostic are 0.00 and 3.25 on Jan 13, 2026. While the company gives a dividend yield of 0.00 per annum.